Quantum dots provide quantitative profile of pancreatic cancer biomarkers on single cells

April 6, 2012, National Cancer Institute

(Phys.org) -- With the aid of a novel set of lipid-coated, targeted quantum dots, researchers at Johns Hopkins University have developed a method for quantifying multiple specific biomarkers on the surfaces of individual cancer cells. This approach to quantitative biomarker detection stands to improve the histopathology methods used to diagnosis pancreatic and other cancers and enable the development of methods to spot cancer cells circulating in the blood stream.

Peter Searson, co-principal investigator of the Center for Cancer Nanotechnology Excellence at Johns Hopkins, led this study. He and his collaborators published their work in the journal Nanomedicine.

The key to the success of this project was developing a method for coating quantum dots, fluorescent nanoparticles that shine brightly at specific , in such a way as to make the water soluble and to keep them from binding to anything but their targets. The solution was to develop a , the same strategy that nature uses to create the highly stable , which is hydrophilic on the outside and renders the coated particles soluble.

The bilayer coating came with another benefit – it enabled the researchers to attach a specific number of biomarker-binding antibodies in a way that each coated quantum dot would only bind to one biomarker protein on the surface of a single cancer cell. The investigators created a set of three quantum dots, each emitting light of distinct color and each targeted to a different well-characterized pancreatic cancer protein.

To determine the amount of each biomarker on a pancreatic cell surface, the investigators spread tumor cells across a plate and added the targeted quantum dots. In a series of experiments, they demonstrated that they could saturate the biomarker proteins on the cell surface, that is, they could ensure that every biomarker protein on the cell surface was binding one quantum dot.

Dr. Searson's team then used high-resolution quantitative fluorescence imaging to measure the amount of light each cell emitted and used that number to calculate the density of each biomarker on the surface of each cell. The researchers were able to make these measurements with sufficient resolution to determine that one of the was not distributed uniformly over the surface of the cell. They also demonstrated that they could make simultaneous measurements of all three targeted biomarkers, a capability essential to the development of high-throughput diagnostic profiling assays.

This work, which is detailed in a paper titled, "Quantitative molecular profiling of biomarkers for pancreatic cancer with functionalized ," was supported in part by the NCI Alliance for Nanotechnology in Cancer, a comprehensive initiative designed to accelerate the application of nanotechnology to the prevention, diagnosis, and treatment of cancer.

Explore further: Evaluating Multiple Biomarkers With Quantum Dots

More information: View abstract here.

Related Stories

Evaluating Multiple Biomarkers With Quantum Dots

May 22, 2007

Quantum dots linked to biological molecules, such as antibodies, have shown promise as a new tool for detecting and quantifying a wide variety of cancer-associated molecules. Now, thanks to detailed studies of how to make ...

Nanosize Rods Light Up Pancreatic Cancer Cells

April 18, 2008

Quantum dots have shown promise as ultrabright contrast agents for use in a variety of cancer imaging studies. Now, a team of investigators at the Multifunctional Nanoparticles in Diagnosis and Therapy of Pancreatic Cancer ...

Biocompatible quantum dot images tumors in live animals

January 20, 2012

Quantum dots, small semiconductor nanoparticles that fluoresce brightly with sharply defined colors, have tremendous promise as biomedical imaging agents except for one problem—most are made from potentially hazardous ...

Mapping Tumor Heterogeneity With Quantum Dots

May 25, 2010

(PhysOrg.com) -- One important discovery made about cancer over the past decade is that as a tumor develops, the molecular identity of its cells begins to diverge. As a result, any given tumor is likely to contain groups ...

Coated Ultrasmall Quantum Dots Suitable for In Vivo Imaging

December 3, 2007

Quantum dots have shown promise in a variety of imaging and therapeutic applications, particularly when they are coated to render them biocompatible. However, such coating can increase the size of quantum dots signficantly, ...

Nanoparticles Provide Detailed View Inside Living Animals

April 18, 2008

Using nanoparticles designed specifically to produce a bright Raman spectroscopic signal, a team of investigators at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (Stanford CCNE) has shown that ...

Recommended for you

New technology for diagnosing immunity to Ebola

January 15, 2018

A promising new approach to detect immunity to Ebola virus infection has been developed by researchers from i-sense in a collaboration between UCL and Imperial College London.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.